Key facts
- It has raised $80.0M; the latest was Early Stage VC ($80.0M) in Feb 2026.
- Notable investors include ARCH Venture Partners, Mubadala Capital, Lingotto, Averin.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Salma Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Salma Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Salma Health
Operator of brain and mental health clinics designed to provide personalized diagnostic evaluations and neuroscience-backed psychiatric care. The company's clinical facilities offer advanced biomarker diagnostics, transcranial magnetic stimulation, esketamine therapies, and virtual intensive outpatient programs, enabling patients suffering from depression, traumatic brain injuries, and cognitive disorders to access coordinated behavioral healthcare and regain emotional well-being.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Founded
- 2025
- Employees
- 57
- Website
- salmahealth.com/
- Ownership
- Privately Held (backing)
Salma Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Salma Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Salma Health in its N-PORT filings yet. We sweep new filings monthly.